Vanda Pharmaceuticals (NASDAQ:VNDA) Stock Price Expected to Rise, HC Wainwright Analyst Says
Vanda Pharmaceuticals (NASDAQ:VNDA – Get Free Report) had its price objective hoisted by equities researchers at HC Wainwright from $18.00 to $20.00 in a note issued to investors on Tuesday,Benzinga reports. The brokerage presently has a “buy” rating on the biopharmaceutical company’s stock. HC Wainwright’s price objective would suggest a potential upside of 339.56% from […]
More Stories
Ameritas Advisory Services LLC Purchases 459 Shares of CSX Corporation (NASDAQ:CSX)
Ameritas Advisory Services LLC increased its holdings in shares of CSX Corporation (NASDAQ:CSX – Free Report) by 4.1% in the...
KBC Group NV Trims Stock Position in Tyson Foods, Inc. (NYSE:TSN)
KBC Group NV lessened its holdings in shares of Tyson Foods, Inc. (NYSE:TSN – Free Report) by 12.2% in the...
Amalgamated Bank Sells 1,496 Shares of Ingredion Incorporated (NYSE:INGR)
Amalgamated Bank cut its holdings in Ingredion Incorporated (NYSE:INGR – Free Report) by 4.7% in the 1st quarter, according to...
Meta Platforms, Inc. (NASDAQ:META) Shares Acquired by Waterfront Wealth Inc.
Waterfront Wealth Inc. lifted its position in shares of Meta Platforms, Inc. (NASDAQ:META – Free Report) by 6.9% during the...
Buttonwood Financial Advisors Inc. Decreases Holdings in Meta Platforms, Inc. (NASDAQ:META)
Buttonwood Financial Advisors Inc. cut its position in shares of Meta Platforms, Inc. (NASDAQ:META – Free Report) by 3.9% during...
Monument Capital Management Raises Stock Position in Meta Platforms, Inc. (NASDAQ:META)
Monument Capital Management raised its stake in Meta Platforms, Inc. (NASDAQ:META – Free Report) by 248.4% in the first quarter,...